Transparency about what's connected, what's AI-enhanced, and what's coming
Transparency Statement
TripSit.ai synthesizes insights using a combination of real API data (ClinicalTrials.gov, PubMed, FDA DailyMed) and AI-generated analysis. We are transparent about which sources are directly connected versus AI-enhanced. All insights should be validated before use in regulatory submissions or clinical decisions.
These sources have direct API integrations with real-time or cached data
Sources
Update Frequency
Real-time with 24-hour cache
Limitations
Sources
Update Frequency
Real-time with 24-hour cache
Limitations
Sources
Update Frequency
Within 2 weeks of congress conclusion
Limitations
Sources
Update Frequency
Real-time with local database sync
Limitations
Sources
Update Frequency
Synced via BioCore platform updates
Limitations
Sources
Update Frequency
Real-time
Limitations
Sources
Update Frequency
Real-time with each insight generation; sentiment trends tracked historically
Limitations
Sources
Update Frequency
Real-time API queries; FAERS database updated quarterly by FDA
Limitations
Sources
Update Frequency
Real-time API queries; CMS updates survey data annually
Limitations
Sources
Update Frequency
Real-time with each insight generation; safety data synced daily
Limitations
Connected RSS Feeds
API-Connected Data
When you see references to ClinicalTrials.gov, PubMed, or FDA DailyMed, these are fetched in real-time from official APIs. The NCT IDs, PMIDs, and drug label URLs are verified and link to actual records.
AI-Generated Analysis
Patient journey narratives, unmet needs analysis, strategic recommendations, and epidemiological context are generated by our AI model. While grounded in medical knowledge, these should be validated before use in formal settings.